In 2021, NEXT Oncology entered into an agreement with the Quirónsalud Group to open two new phase I clinical trial centers in Spain, one in Madrid and another in Barcelona. The venture increases global access to new agents and anticancer therapies for cancer patients.
Early phase clinical trials create an opportunity for patients to access new therapies that are not yet available and undergo treatment in a safe setting where they will be more closely followed throughout the trial. Additionally, early phase clinical research may have a significant impact on disease prognosis and improved outcomes for cancer patients in the future.
If you are interested in participating in trials at NEXT Oncology, please contact us to learn more.
1 Calle Diego de Velazquez 1
28223 Pozuelo de Alarcón Madrid, Spain
Phone: Dial 011 (+34) 932-381-661
Open Monday-Friday 8:00 AM to 5:00 PM
